You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment

 

Online download statistics by month:

Online download statistics by month: July 2024 to July 2025

AbstractFullPdf
Jul 2024348352148
Aug 2024372373541
Sep 2024374372822
Oct 2024293294184
Nov 2024349356189
Dec 2024235236121
Jan 2025149151103
Feb 202549250181
Mar 2025453455121
Apr 2025165165153
May 2025120121143
Jun 20256767117
Jul 2025330
Total342034462723